TRANSTEC 52.5 MICROGRAMS/H TRANSDERMAL PATCH

Active substance: BUPRENORPHINE

View full screen / Print PDF » Download PDF ⇩

Transcript
PACKAGE LEAFLET: INFORMATION FOR THE USER

Transtec 35 micrograms/h / 52.5 micrograms/h /
70 micrograms/h transdermal patch
®

Buprenorphine
Read all of this leaflet carefully before you start using this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their
symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your
doctor or pharmacist.
In this leaflet:
1.
What Transtec is and what it is used for
2.
Before you use Transtec
3.
How to use Transtec
4.
Possible side effects
5.
How to store Transtec
6.
Further information
1.
WHAT TRANSTEC IS AND WHAT IT IS USED FOR
Transtec is an analgesic (a pain-relieving medicine) intended to relieve moderate to severe cancer pain and severe
pain that has not responded to other types of painkillers. Transtec acts through the skin. When the transdermal
patch is applied to the skin, the active substance buprenorphine passes through the skin into the blood. Buprenorphine is an opioid (strong pain reliever), which reduces pain by acting on the central nervous system (specific
nerve cells in the spinal cord and in the brain). The effect of the transdermal patch lasts for up to four days.
Transtec is not suitable for the treatment of acute (short-lasting) pain.
2.
BEFORE YOU USE TRANSTEC
Do not use Transtec,
- if you are allergic (hypersensitive) to the active substance buprenorphine or any of the other ingredients of
Transtec;
- if you are dependent on strong pain relievers (opioids);
- if you suffer from a disease in which you have or may have great difficulty breathing
- if you are taking monoamine oxidase (MAO) inhibitors (certain medicines used to treat depression) or you
have taken this type of medicine in the last two weeks (see "Taking other medicines");
- if you suffer from myasthenia gravis (a certain type of severe muscle weakness);
- if you suffer from delirium tremens (confusion and trembling caused by abstinence from alcohol following
habitual excessive drinking or occurring during an episode of heavy alcohol consumption);
- if you are pregnant.
Transtec must not be used to treat withdrawal symptoms in drug-dependent persons.
Take special care with Transtec,
- if you have recently drunk a lot of alcohol;
- if you suffer from seizures or convulsions (fits)
- if your consciousness is disturbed (feeling light-headed or faint) for an unknown reason;
- if you are in a state of shock (cold sweat might be a sign of it);
- if the pressure in your skull is increased (for instance after head injury or in brain disease), and artificial
respiration is not possible;
- if you have difficulty breathing or are taking other medicines that may make you breathe more slowly or weakly
(see "Taking other medicines");
- if your liver does not work properly;
- if you are inclined to abuse medicines or drugs.
Please consult your doctor if any of these statements apply to you or were applicable to you at any time in the past.
Also, please be aware of the following precautions:
- Some people may become dependent on strong pain relievers such as Transtec when they use them over a long
period of time. They may have withdrawal effects when they stop using them (see “If you stop using Transtec”).
- Fever and external heat may lead to larger quantities of buprenorphine in the blood than normal. Also, external heat
may prevent the transdermal patch from sticking properly. Therefore, do not expose yourself to external heat
(e.g. sauna, infra-red lamps, electric blankets, hot water bottles) and consult your doctor if you have fever.
- Transtec should not be used in persons below the age of 18 years, because no experience has so far been
gained in this age group.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including
medicines obtained without a prescription.
- Transtec must not be used together with monoamine oxidase (MAO) inhibitors (certain medicines used to
treat depression), or if you have taken this type of medicine for the last 2 weeks.
- Transtec may make some people feel drowsy, sick, or faint or make them breathe more slowly or weakly.
These side effects may be intensified if other medicines that may produce the same effects are taken at the same
time. These other medicines include other strong pain relievers (opioids), certain sleeping pills, anaesthetics, and
medicines used to treat certain psychological diseases such as tranquillizers, anti-depressants, and neuroleptics.
- If Transtec is used together with some medicines, the effects of the transdermal patch may be increased.
These medicines include e.g. certain anti-infectives/anti-fungals (e.g. containing erythromycin or ketoconazole) or
HIV medicines (e.g. containing ritonavir)
- If Transtec is used together with other medicines, the effects of the transdermal patch may be reduced. These
medicines include certain products, e.g. dexamethasone; medicines to treat epilepsy (e.g. containing carbamazepine, or phenytoin) or medicines for tuberculosis (e.g. rifampicin).
Using Transtec with food and drink
You should not drink alcohol while using Transtec. Alcohol may intensify certain side effects of the transdermal
patch and you may feel unwell. Drinking grapefruit juice may intensify the effects of Transtec.
Pregnancy
There is not sufficient experience regarding the use of Transtec in pregnant women. Therefore do not use Transtec if you are pregnant.
Ask your doctor or pharmacist for advice before taking any medicine.
Breast-feeding
Buprenorphine, the active substance contained in the transdermal patch, inhibits milk formation and passes into
the breast milk. Therefore, do not use Transtec if you are breast-feeding.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Transtec may make you feel dizzy or drowsy or experience blurred or double vision and affect your reactions to such
an extent that you may not react adequately or quickly enough in the event of unexpected or sudden occurrences.
This applies particularly
- at the beginning of treatment,
- when your dosage is changed,
- when you switch to Transtec from another pain reliever,
- if you also use other medicines that act on the brain,
- if you drink alcohol.
If you are affected, you should not drive or operate machinery whilst using Transtec. This applies also at the end of
treatment with Transtec. Do not drive or operate machinery for at least 24 hours after the patch has been removed.
Discuss with your doctor or pharmacist if you are unsure about anything.
3.
HOW TO USE TRANSTEC
Transtec is available in three strengths: Transtec 35 micrograms/h transdermal patch, Transtec 52.5 micrograms/h transdermal patch and Transtec 70 micrograms/h transdermal patch.
The choice of which strength of Transtec will suit you best will be made by your doctor. During treatment your
doctor may change which transdermal patch you use to a smaller or larger one if necessary.
Always use Transtec exactly as your doctor has told you. You should check with your doctor or pharmacist if you
are not sure.
The usual dose is:
Adults
Unless your doctor has told you differently, attach one Transtec transdermal patch (as described in detail below)
and change it after 4 days at the latest. For convenience of use, you can change the transdermal patch twice a
week at the same days, e.g. always on Monday mornings and Thursday evenings. To help you remember when to
change your transdermal patch, you should make a note on the calendar on the outer packaging. If your doctor
has advised you to take other pain relievers in addition to the transdermal patch, strictly follow the doctor's
instructions, otherwise you will not fully benefit from treatment with Transtec.
Patients under 18 years of age
Transtec should not be used in persons below the age of 18 years, because no experience has so far been gained
in this age group.
Elderly patients
No dosage adjustment is needed for elderly patients.
Patients with kidney disease / dialysis patients
In patients with kidney disease and in dialysis patients, no dosage adjustment is necessary.
Patients with liver disease
In patients with liver disease, the intensity and duration of action of Transtec may be affected. If this applies to
you, your doctor will check on you more closely.
Method of administration
Before applying the transdermal patch
- Choose an area of skin which is flat, clean and
hairless on your upper body, preferably on the
chest below the collar-bone or on the upper
part of the back (see adjacent illustrations). Call
assistance if you cannot apply the transdermal patch
yourself.
Chest
Back
- If the chosen area has hairs, cut them off with a pair of scissors. Do not shave them off!
- Avoid skin which is red, irritated or has any other blemishes, for instance large scars.
- The area of skin you choose must be dry and clean. If necessary, wash it with cold or lukewarm water. Do
not use soap or other detergents. After a hot bath or shower, wait until your skin is completely dry and cool.
Do not apply lotion, cream or ointment to the chosen area. This might prevent your transdermal patch from
sticking properly.
Applying the transdermal patch:
Step 1:
Each transdermal patch is sealed in a sachet. Just before use, open the sachet by tearing at
the notch. Take out the transdermal patch.

Step 2:
The sticky side of the transdermal patch is covered with a silvery protective foil. Carefully peel
off half the foil. Try not to touch the sticky part of the transdermal patch.

Step 3:
Stick the transdermal patch onto the area of skin you have chosen and remove the
remaining foil.
Step 4:
Press the transdermal patch against your skin with the palm of your hand for about 30 seconds. Make sure that the whole transdermal patch is in contact with your skin, especially
at the edges.
Wearing the transdermal patch
You may wear the transdermal patch for up to 4 days. Provided that you have applied the transdermal patch correctly,
there is little risk of it coming off. You may shower, bathe or swim while wearing it. However, do not expose the
transdermal patch to extreme heat (e.g. sauna baths, infra-red lamps, electric blankets, hot water bottles).
In the unlikely event that your transdermal patch falls off before it needs changing, do not use the same transdermal
patch again. Stick a new one on straight away (see "Changing the transdermal patch" below).
Changing the transdermal patch
- Take the old transdermal patch off.
- Fold it in half with the sticky side inwards.
- Throw it away carefully, out of the reach and sight of children.
- Stick a new transdermal patch on a different skin site (as described above). Wait at least one week before
using the same site again.
Duration of treatment
Your doctor will tell you how long you may use Transtec. Do not stop using Transtec on your own account,
because pain may return and you may feel unwell (see also "If you stop using Transtec" below).
If you have the impression that the effect of the Transtec transdermal patch is too weak or too strong, tell your
doctor or pharmacist.
If you use more Transtec than you should
If this happens there may be signs of an overdose of the substance buprenorphine. An overdose may intensify

93012375_GI_TRANSTEC_PFLASTER_EN 1

14.07.11 12:59

the side effects of buprenorphine such as drowsiness, nausea, and vomiting. You may get pin-point pupils and
breathing may become slow and weak. You may also get cardiovascular collapse.
As soon as you discover that you have used more transdermal patches than you should, remove the excess
transdermal patches and talk to a doctor or pharmacist.
If you forget to use Transtec
If you forget an application, stick a new transdermal patch on as soon as you remember. You will then need to change
your routine, e.g. if you usually apply your transdermal patches on Mondays and Thursdays, but you forget and don’t
stick on a new transdermal patch until Wednesday, you will need to change your transdermal patches on Wednesdays
and Saturdays from then on. Make a note of the new pair of days on the calendar on the outer packaging. If you are very
late changing your transdermal patch, pain may return. In this case please contact your doctor.
Never apply twice the number of transdermal patches to make up for the forgotten application!
If you stop using Transtec
If you interrupt or finish using Transtec too soon, pain may return. If you wish to stop use on account of unpleasant side effects, please consult your doctor. He/she will tell you what can be done and whether you can be
treated with other medicines.
Some people may experience withdrawal-effects when they have used strong pain relievers for a long time and
stop using them. The risk of having effects after you stop using Transtec is very low. However, if you feel agitated,
anxious, nervous or shaky, if you are overactive, have difficulty sleeping or digestion problems, tell your doctor.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4.
POSSIBLE SIDE EFFECTS
Like all medicines, Transtec can cause side effects, although not everybody gets them.
Side effects are classified as follows:
Very common:
Common:
more than 1 out of 10 persons
more than 1 out of 100 persons
and less than 1 out of 10 persons
Uncommon:
Rare:
more than 1 out of 1000 persons
more than 1 out of 10000 persons
and less than 1 out of 100 persons
and less than 1 out of 1000 persons
very rare:
less than 1 out of 10,000 persons
The following side effects have been reported:
Immune system disorders
Very rare:
serious allergic reactions (see below)
Metabolism and nutrition disorders
Rare:
loss of appetite
Psychiatric disorders
Uncommon:
confusion, sleep disorder, restlessness
Rare:
illusions such as hallucinations, anxiety and nightmares, reduced sex drive
Very rare:
dependence, mood swings
Nervous system disorders
Common:
dizziness, headache
Uncommon:
various degrees of sedation (calmness), ranging from tiredness to muzziness
Rare:
difficulty concentrating, speech disorder, muzziness, disturbed balance, abnormal skin sensations
(numbness, prickling or burning sensations)
Very rare
muscle twitching, taste disorders
Eye disorders
Rare:
visual disturbance, blurred vision, swollen eyelids
Very rare:
pin-point pupils
Ear disorders
Very rare:
ear pain
Heart and blood circulation disorders
Uncommon:
circulatory disorders (such as low blood pressure or, rarely, even circulatory collapse)
Rare:
hot flushes
Chest and lung disorders
Common:
shortness of breath
Rare:
difficulty breathing (respiratory depression)
Very rare:
abnormally rapid breathing, hiccups
Digestive system disorders
Very common: nausea (feeling sick)
Common:
vomiting, constipation
Uncommon:
dry mouth
Rare:
heartburn
Very rare:
retching
Skin disorders (generally at the site of application)
Very common: redness, itching
Common:
skin changes (exanthema, generally on repeated use), sweating
Uncommon:
rash
Rare:
hives
Very rare:
pustules, small blisters
Urinary system disorders
Uncommon:
difficulty in passing water, urine retention (less urine than normal)
Reproductive system disorders
Rare:
erection difficulties
General disorders
Common:
oedema (e.g. swelling of the legs), tiredness
Uncommon:
weariness
Rare:
withdrawal symptoms (see below), administration site reactions
Very rare:
chest pain
If you notice any of the side effects listed above, tell your doctor as soon as possible.
In some cases delayed allergic reactions occurred with marked signs of inflammation. In such a case you should
stop using Transtec after you have talked to your doctor.
If you experience swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty
in swallowing or breathing, hives, fainting, yellowing of the skin and eyes (also called jaundice), remove
the transdermal patch and call your doctor immediately or seek help at the casualty department of the
nearest hospital. These can be symptoms of a very rare serious allergic reaction.
Some people may have withdrawal symptoms when they have used strong pain relievers for a long time and stop using
them. The risk of having withdrawal effects when you stop using Transtec is low. However, if you feel agitated, anxious,
nervous or shaky, if you are overactive, have difficulty sleeping or digestion problems, tell your doctor.
If any of the side effects gets serious, or if you notice any side effects not mentioned in this leaflet, please tell
your doctor or pharmacist.
5.
HOW TO STORE TRANSTEC
Keep out of the reach and sight of children.
Do not use Transtec after the expiry date which is stated on the carton and on the sachet after "Expiry date
(month/year):". The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of
medicines no longer required. These measures will help to protect the environment.
6.
FURTHER INFORMATION
What Transtec contains
The active substance in Transtec is buprenorphine.
Transtec 35 micrograms/h
Each transdermal patch contains 20 mg buprenorphine and releases about
transdermal patch
35 micrograms of buprenorphine per hour.
The area of the transdermal patch containing the active substance is 25 cm2.
Transtec 52.5 micrograms/h Each transdermal patch contains 30 mg buprenorphine and releases about
transdermal patch
52.5 micrograms of buprenorphine per hour.
The area of the transdermal patch containing the active substance is 37.5 cm2.
Transtec 70 micrograms/h
Each transdermal patch contains 40 mg buprenorphine and releases about
transdermal patch
70 micrograms of buprenorphine per hour.
The area of the transdermal patch containing the active substance is 50 cm2.
The other ingredients in Transtec are:
Adhesive matrix: [(Z)-octadec-9-en-1-yl] oleate; povidone K90; 4-oxopentanic acid; poly[acrylic acid-co-butylacrylate-co-(2-ethylhexyl)acrylate-co-vinylacetate] (5:15:75:5), cross-linked (buprenorphine-containing area) or not
cross-linked (area without buprenorphine); foil separating both matrix areas: poly(ethyleneterephthalate)-foil;
backing layer: poly(ethyleneterephthalate)-tissue. The release liner which is removed before applying the transdermal patch consists of siliconised poly(ethyleneterephthalate)-foil coated on one side with aluminium.
What Transtec looks like and contents of the pack
Transtec transdermal patches are skin-coloured with rounded corners and are imprinted
Transtec 35 µg/h, buprenorphinum 20 mg
Transtec 52.5 µg/h, buprenorphinum 30 mg
Transtec 70 µg/h, buprenorphinum 40 mg
Transtec comes in cartons containing 4 transdermal patches individually sealed in sachets.
Marketing Authorisation Holder and Manufacturer
Grünenthal GmbH, 52099 Aachen, Germany
For further information contact:
Napp Pharmaceuticals Limited, Cambridge Science Park, Milton Road, Cambridge CB4 0GW, UK.
Mundipharma Pharmaceuticals Limited, Millbank House, Arkle Road, Sandyford, Dublin 18, Republic of Ireland.

This leaflet is also available in large print, Braille or as
an audio CD.
To request a copy, please call the RNIB Medicine
Information line
UK: 0800 198 5000 (free of charge)
Reference number: 04539/0014
ROI: 0044 1733 37 53 70
Reference number: 1032/001/001
You will need to give details of the product name and
reference number.
Product name: Transtec patches
This medicinal product is authorised in the Members States of the EEA under the following names:
Austria
Transtec®
Belgium
Transtec®
Denmark
Transtec®
Germany
Transtec® PRO
Ireland
Transtec®
Italy
Transtec®
Luxembourg
Transtec®
Portugal
Transtec®
Slovenia
Transtec®
Spain
Transtec®
United Kingdom Transtec®
This leaflet was last revised in
July 2011
TRANSTEC is a registered trade mark of Grünenthal GmbH, and is used under licence.
NAPP and the “NAPP” device (logo) are registered trade marks of the Napp Pharmaceutical Group.
2007 - 2011 Napp Pharmaceuticals Ltd.
®

©

93012375

93012375_GI_TRANSTEC_PFLASTER_EN 2

6505747
50/007/023

14.07.11 12:59

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)